What is Mikra?
Based in British Columbia, Canada, Mikra operates at the intersection of advanced biotechnology and consumer wellness. The company specializes in the development of high-performance supplement formulas engineered to optimize human physiology. By targeting the reduction of oxidative stress and the enhancement of cognitive function, Mikra addresses the growing demand for science-backed health solutions. Its market position is defined by a commitment to rigorous formulation standards, aiming to provide consumers with measurable improvements in energy and mental clarity. As the wellness industry shifts toward evidence-based interventions, Mikra remains a key player in the evolution of functional health products.
How much funding has Mikra raised?
Mikra has raised a total of $8.5M across 1 funding round:
Unspecified
$8.5M
Unspecified (2022): $8.5M with participation from Lifeist Wellness
Key Investors in Mikra
Lifeist Wellness
Lifeist Wellness is a global health platform dedicated to connecting consumers with innovative, safe, and effective wellness solutions that address diverse physiological needs.
What's next for Mikra?
The recent influx of capital provides Mikra with the necessary resources to scale its operations and expand its reach within the competitive wellness landscape. Moving forward, the company is expected to prioritize the commercialization of its core product lines while potentially exploring new research avenues to combat cellular aging. By leveraging this major enterprise-level funding, Mikra is poised to strengthen its supply chain and enhance its digital distribution infrastructure. The strategic focus will likely remain on maintaining product efficacy while navigating the complexities of international health regulations, ensuring that the brand remains a leader in the cognitive and metabolic health space.
See full Mikra company page
